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ABSTRACT
Objective: This study was undertaken to determine the ability ofhistory taking alone, compared with
pregnancy testing, to identify early pregnancies among potential female measles vaccinees.
Methods: As part of an institution-wide measles immunization program, 326 female health care
workers (HCWs) who denied being pregnant underwent a urine pregnancy test prior to vaccination.
Results: Of the 326 women, 3 had positive pregnancy tests and were ultimately confirmed to be
pregnant. Although all 3 women denied the possibility of pregnancy prior to testing, 2 had been
unable to give an exact date for their last menstrual period (LMP).
Conclusions: In this group of 326 northern New England HCWs being immunized against mea-
sles during an outbreak, history taking alone failed to identify 3 pregnancies. Ifthe inability to give an
exact date of the LMP had been included as a discriminator, 2 additional pregnancies could have
been suspected, but 1 pregnancy still would have gone undetected. (C) 1994 Wiley-Liss, Inc.
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lthough any possible effect of measles vaccine
on fetal development is presently unknown,
because it is a live-virus vaccine, its use is felt to be
contraindicated in pregnant women.
-6 Current
guidelines state that identifying pregnancy in po-
tential vaccinees by history alone is sufficient and
pregnancy testing is not considered to be essen-
tial. 1’2’4’5 The literature, however, contains no
studies of the effectiveness of history taking in de-
termining whether potential vaccinees are preg-
nant.
During the winter of 1992-93, a measles out-
break occurred in Vermont, necessitating a mass
immunization program at the Medical Center Hos-
pital of Vermont, the state’s 500-bed tertiary care
teaching hospital. This program provided an op-
portunity to quantitate the ability of history taking
alone, compared with pregnancy testing, to identify
pregnant hospital employees who presented for mea-
sles immunization.
SUBJECTS AND METHODS
When it became evident that the state was experi-
encing a measles outbreak, the hospital developed
an institution-wide measles vaccination program.
In the 2nd week of February 1993, all hospital
employees, housestaff, and attending physicians
born after 1957 were required to be evaluated at a
central location for evidence of immunity to mea-
sles. Evidence of immunity was defined as birth
before January 1, 1957, laboratory evidence of
immunity to measles, documentation of physician-
diagnosed measles, or documentation of the receipt
of 2 doses of measles vaccine.
)‘ All of those without
evidence of immunity were questioned with regard
to contraindications to vaccination, including al-
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lergy to eggs or neomycin, and altered immuno-
competence. In addition, all women between the
ages of 15 and 50 years were advised that pregnant
women should not receive the measles vaccine and
were asked if they were pregnant. Women who had
no evidence of immunity, who had no contraindica-
tions to measles vaccination, and who stated they
were not pregnant were asked to record the date of
their last menstrual period (LMP) and sign the
statement, "I do not believe I am pregnant and will
wait until 3 months after vaccination before getting
pregnant." Prior to being immunized, all women
who denied being pregnant and who had signed the
above statement had a urine pregnancy test (Abbott
TestPack Plus, Abbott Laboratories, Abbott Park,
IL) performed. If this test was negative, they were
immunized.
RESULTS
A total of 456 individuals had no evidence of im-
munity to measles, denied contraindications to mea-
sles vaccination including pregnancy, and agreed to
be immunized. Of the 456, 128 were men and 328
were women. Of the 328 women, 2 refused preg-
nancy testing because of the history of either a total
abdominal hysterectomy or a bilateral salpingo-
oophorectomy. Of the 326 women who underwent
a urine pregnancy test, 323 were negative and 3
were positive. These 3 cases are presented in more
detail:
Case 1. A neurosurgery nurse stated she was not
pregnant and signed the required statement, but
could not remember the date of her LMP.
Case 2. An admitting clerk was seen on Febru-
ary 15. She stated she was not pregnant, signed
the required statement, and listed her LMP as
"? 1/19/93."
Case 3. A nutrition services worker was seen on
February 15. She stated she was not pregnant,
signed the required statement, and listed her LMP
as "2/4/93."
should one determine that a woman is not pregnant
before she is vaccinated? The 3 most authoritative
groups2’4’5 concerning measles immunization of
women recommend history taking alone as the
means to exclude pregnancy.
In its October 1991 "Technical Bulletin on Im-
munization During Pregnancy," the American Col-
lege of Obstetricians and Gynecologists states:
Before a women is vaccinated, it should be deter-
mined whether she is pregnant. Because of the the-
oretical risk to the fetus of infection with live-virus
vaccines, women of childbearing age should re-
ceive measles, rubella, and mumps vaccines only if
they are not pregnant. Testing for pregnancy, how-
ever, is not essential. Reasonable precautions before
giving these vaccines include asking women if they
are pregnant, explaining the theoretical risks, and
advising them not to become pregnant for 3 months
after vaccination.
4
The most recent recommendation of the Advi-
sory Committee on Immunization Practices of" the
Centers for Disease Control regarding measles
states:
Live measles vaccine, when given as a component
of MR (measles, rubella vaccine, live) or MMR
(measles, mumps, and rubella vaccine, live), should
not be given to women known to be pregnant or
who are considering becoming pregnant within the
next 3 months. Women who are given monovalent
measles vaccine should not become pregnant for at
least 30 days after vaccination. This precaution is
based on the theoretical risk of fetal infection, al-
though no evidence substantiates this theoretical
risk. Considering the importance of protecting ad-
olescents and young adults against measles, asking
women if they are pregnant, excluding those who
are, and explaining the theoretical risks to the oth-
ers before vaccination are sufficient precautions.
2
All 3 pregnancies were subsequently confirmed.
DISCUSSION
Because of the theoretical risk to the fetus of infec-
tion with a live-virus vaccine, women of childbear-
ing age should receive measles, rubella, and mumps
vaccines only if they are not pregnant.
1-6 How
The 1991 Report of the Committee on Infec-
tious Diseases of the American Academy of Pediat-
rics supports this approach as well.
5
Despite the consistency of these recommenda-
tions, the sensitivity of history taking alone in iden-
tifying unsuspected pregnancies prior to immuni-
zation has not previously been reported. Our need
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to rapidly immunize a large number of predomi-
nantly female health care workers (HCWs) pro-
vided the opportunity to study this issue. Three
(0.9%) of 326 women who, by carefully obtained
and documented history, did not believe they were
pregnant were found to be pregnant by urine preg-
nancy testing.
Could any systematic bias account for these find-
ings? As all 3 women were subsequently confirmed
as being pregnant, false-positive tests were not the
explanation in this series. Most currently available
office urine pregnancy tests have a specificity of
nearly 100%.
7 Of greater concern is the fact that
many employees may have known that a urine preg-
nancy test would be performed prior to receiving
the measles immunization. It is possible that or
more of the 3 women with subsequently positive
tests actually thought they were pregnant and were
"testing the system." Such an explanation might
account for case and case 2 being uncertain of the
date of their LMPs. In this series, if only those
who denied being pregnant and listed a definite
LMP had been considered not pregnant, history
taking alone would have failed to identify only a
single pregnancy. Adding the inability to give a
precise date of the LMP as a discriminator may not
be a practical strategy, however, as many women
would presumably be unable to give such a date,
limiting the specificity of this approach.
In practice, the use of pregnancy testing to cor-
roborate a negative history is inconsistent. In the
1992-93 outbreak in Vermont, the Vermont De-
partment of Health did not employ pregnancy test-
ing in their measles immunization program while
the hospital did. In a hospital-wide measles vacci-
nation program reported from Hartford, CT, preg-
nancy tests were administered only to those employ-
ees with "uncertain pregnancy status,
’’8 while a
similar vaccination program rom a hospital in
Stony Brook, NY, reported in the same journal
tested all female employees of childbearing age.
9
A strategy to decrease the potential number of
vaccinees, and the possibility ofan undetected preg-
nancy, would be to provide prevaccination sero-
logic screening. At our hospital, approximately 93%
of tested I-ICWs are seropositive for measles anti-
body. Recent studies have shown that 90-94% of
new or current medical personnel have antibody to
measles virus. 1’11 In a population with a high
prevalence of seropositivity, the use of a sensitive
antibody screening test could identify the small sub-
set of nonimmune individuals who need to be im-
munized against measles. Such a strategy has been
shown to be cost effective.
12 In settings where rapid
or widespread immunization is necessary, such as
outbreaks or exposures or where return of those
screened is not assured, prevaccination screening is
problematic and is not recommended.
13
The urine pregnancy test used in this program
has a sensitivity of 5 0 miU/ml of human chorionic
gonadotropin and should identify pregnancy by the
time of the 1st expected menstrual day with a sensi-
tivity of 99.3%.
7 Thus, a small number of preg-
nant women with false-negative tests or very early
gestations will not be detected despite urine preg-
nancy testing.
To summarize, history taking alone, as currently
recommended, (ailed to identify 3 unsuspected
pregnancies in a group of 326 I--ICWs. Two of
these 3 women, despite believing themselves not to
be pregnant, were unable to provide the exact date
of their LMP. These observations were made in a
cohort of northern New England I-ICWs in an
outbreak setting. Whether they are generalizable to
other populations, locations, or settings is unknown.
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